39

United Laboratories International Holdings LtdHKG 3933 Stock Report

Last reporting period 31 Dec, 2023

Updated 12 Nov, 2024

Last price

Market cap $B

2.135

Small

Exchange

XHKG - Hong Kong Exchange

3933.HK Stock Analysis

39

Uncovered

United Laboratories International Holdings Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

102/100

High score

Market cap $B

2.135

Dividend yield

12.13 %

Shares outstanding

1 817.03 B

The United Laboratories International Holdings Ltd. is an investment company, which engages in the research, development, production and operation of medical intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical preparations. The company employs 13,600 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.

View Section: Eyestock Rating